Clinical Data Registry Tracking Multiple Sclerosis | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Clinical Data Registry Tracking Multiple Sclerosis

December 4, 2017
by David Raths
| Reprints
NARCRMS will include neuroimaging, genetic markers, clinical and cognitive assessments, and specimen collection

Clinical data registries are playing an increasingly important role in quality improvement, value-based care and research, and the pace of new registry development is increasing. For instance, the Consortium of Multiple Sclerosis Centers has developed an MS registry and longitudinal database of clinical records and patient-centered outcomes.

The mission of the North American Registry for Care and Research in MS (NARCRMS) is to provide clinicians and researchers with a greater, more. Through information sharing, NARCRMS seeks to improve the understanding of MS and facilitate care at every level.

Physician-collected data will include neuroimaging, genetic markers, clinical and cognitive assessments, and specimen collection and testing for the study and validation of biomarkers of disease progression. Patient-reported outcomes focused on the challenges of MS and its impact on daily life will complement physician-generated information.

"NARCRMS addresses a pressing need in MS research and care, "said Cyndi Zagieboylo, president and CEO of the National MS Society, in a prepared statement. "By collaborating with NARCRMS, we can more effectively utilize data to advance our understanding of MS and do more to help people with MS live their best lives."

NARCRMS is collaborating with other MS registries, clinicians, researchers, and people living with MS.  It will allow for the linkage of centers and facilitates along with regional analysis of data by state, region, and zip code. NARCRMS will facilitate the recruitment of participants for clinical trials as the registry grows.

To date NARCRMS has recruited 10 centers and enrolled 113 patients with an additional three centers expected to join shortly.

This clinician-driven registry builds on a parallel patient-driven registry called the North American Research Committee on Multiple Sclerosis (NARCOMS). NARCOMS is the oldest patient-driven registry in the U.S. It uses the power of the patient experience to improve clinical care and quality of life for persons living with MS.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.